We offer customized end-to-end bioanalytical solutions to achieve your milestones effectively and on schedule, supporting the development of a wide range of therapeutics from discovery through Phase IV. We have a solid foundation of experience in standardized and customized development, validation, and production of pharmacokinetic and immunogenicity assays for biosimilars, biobetters, and new biological entities (NBEs).